Home

Report

Hematologic Cancer Opportunities for Patient Equality (HOPE)

Hematologic Cancer Opportunities for Patient Equality (HOPE)

IQVIA
Pages 13 Pages

This summary captures insights from a multi-stakeholder discussion on access to hematologic cancer therapies. It highlights disparities across regions driven by HTA variability, funding constraints, and infrastructure limitations. Despite rapid innovation in hematology—including CAR T and novel biologics—access remains uneven. The report calls for coordinated policy action, improved clinical trial alignment, and health system readiness to ensure timely and equitable access to life-saving therapies.

Join for free to read

You Might Also Like


ONCOLOGY WOMEN'S HEALTH- Addressing the Challenges and Opportunities in Gynecologic Cancer Research
White Paper ONCOLOGY WOMEN'S HEALTH- Addressing the Challenges and…
Premier Research

City of Hope
Case Study City of Hope
LabKey

CITY OF HOPE IMPROVES PATIENT EXPERIENCE AND SPEEDS CLINICAL RESEARCH WITH OCR SOFTWARE FOR EHR
Case Study CITY OF HOPE IMPROVES PATIENT EXPERIENCE AND SPEEDS CLINICAL…
Foxit Software

City of Hope Improves Patient Experience and Speeds Clinical Research with OCR Software for EHR
Case Study City of Hope Improves Patient Experience and Speeds Clinical…
Foxit Software

More from IQVIA


Access Challenges in the Cancer Patient Journey
White Paper Access Challenges in the Cancer Patient Journey
IQVIA

Cancer Won’t Wait: Building Resilience in Cancer Screening and Diagnostics in Europe
Report Cancer Won’t Wait: Building Resilience in Cancer Screening and…
IQVIA

India in Focus: Lung Cancer Trial Readiness
White Paper India in Focus: Lung Cancer Trial Readiness
IQVIA

Pathway to Success in Cancer Treatment
Report Pathway to Success in Cancer Treatment
IQVIA
© 2026 Contentree.  All Rights Reserved   |   Privacy and Cookies   |   Legal   |   Do not sell my info